EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

From Renal Markers to Muscle Mass: A Sarcopenia Index Predicts Outcomes in Coronary Artery Disease Patients with Aortic Valve Sclerosis

Yifeng Zhang, Hui Chen, Xihao Du, Yanping Wang, Jiawei Chen, Mirenuer Aikebaier, Shuyao Shan, Ling Yang, Anqi Zhao, Wei Chu, Yehong Liu, Zhongli Chen und 1 weitere

Cardiorenal Medicine · 2025

DOI: 10.1159/000545619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, 2025. Verfasst von Yifeng Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Sarcopenia, Coronary Artery Disease, Aortic Valve, Heart Valve Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal function plays a pivotal role in influencing various diseases, particularly cardiovascular conditions. Renal markers show strong associations with coronary artery disease (CAD), aortic valve sclerosis (AVSc), and sarcopenia. The Sarcopenia Index (SI), a biomarker derived from renal markers, serves a dual purpose: it precisely quantifies muscle mass while also acting as a prognostic indicator for adverse cardiovascular outcomes, especially in patients with concurrent CAD and AVSc.

Methods

A retrospective analysis was performed on consecutive CAD patients treated from 2013 to 2014. The SI was calculated using the formula [serum creatinine (mg/dL)/cystatin C (mg/dL)] × 100. The primary composite endpoint was cardiovascular death or rehospitalization for heart failure or acute coronary syndrome events. The secondary endpoint included the primary endpoint plus all-cause mortality. Kaplan-Meier analysis, and Cox proportional hazards modeling was applied to analyze the association between SI and outcomes Results: Among the 1,123 CAD patients, 277 had AVSc. Patients with AVSc had significantly lower SI, which was independently associated with AVSc presence (OR=1.750, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaCoronary Artery DiseaseAortic ValveHeart Valve DiseasesHumansMaleFemaleRetrospective StudiesAgedBiomarkersSclerosisPrognosisMiddle AgedCreatinineCystatin C

Stichwörter der Autor:innen

Aortic valve sclerosisCardiovascular outcomesCoronary artery diseaseRisk stratificationSarcopenia index

Substanzen

BiomarkersCreatinineCystatin C

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiology, Shanghai East Hospital Tongji University School of Medicine, Shanghai, China.
  • Huangpu District Center for Disease Control and Prevention Shanghai China, Shanghai, China.

Zitieren

APA

Zhang, Y., Chen, H., Du, X., Wang, Y., Chen, J., Aikebaier, M., Shan, S., Yang, L., Zhao, A., Chu, W., Liu, Y., Chen, Z., & Yang, K. (2025). From Renal Markers to Muscle Mass: A Sarcopenia Index Predicts Outcomes in Coronary Artery Disease Patients with Aortic Valve Sclerosis. Cardiorenal Medicine. https://doi.org/10.1159/000545619

Vancouver

Zhang Y, Chen H, Du X, Wang Y, Chen J, Aikebaier M, et al. From Renal Markers to Muscle Mass: A Sarcopenia Index Predicts Outcomes in Coronary Artery Disease Patients with Aortic Valve Sclerosis. Cardiorenal Medicine. 2025. doi:10.1159/000545619

BibTeX
@article{Zhang2025,
  author = {Zhang, Yifeng and Chen, Hui and Du, Xihao and Wang, Yanping and Chen, Jiawei and Aikebaier, Mirenuer and Shan, Shuyao and Yang, Ling and Zhao, Anqi and Chu, Wei and Liu, Yehong and Chen, Zhongli and Yang, Ke},
  title = {From Renal Markers to Muscle Mass: A Sarcopenia Index Predicts Outcomes in Coronary Artery Disease Patients with Aortic Valve Sclerosis},
  journal = {Cardiorenal Medicine},
  year = {2025},
  doi = {10.1159/000545619}
}
Kostenlos starten →